Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Cost of Goods Sold

Aquestive Therapeutics Inc Cost of Goods Sold Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Cost of Goods Sold from 2006 to 2018.
  • Aquestive Therapeutics Inc Cost of Goods Sold for the quarter ending December 12, 2018 was $5m a -17.74% decrease of -1m year over year
  • Aquestive Therapeutics Inc Cost of Goods Sold for the last 12 months ending December 12, 2018 was $21m a -1.35% decrease of 0m year over year
  • Aquestive Therapeutics Inc Annual Cost of Goods Sold for 2018 was $21m a 5.57% increase of 1m from 2017
  • Aquestive Therapeutics Inc Annual Cost of Goods Sold for 2017 was $20m a 17.37% increase of 3m from 2016
  • Aquestive Therapeutics Inc Annual Cost of Goods Sold for 2016 was $16m a 90.09% increase of 15m from 2015
Other Income Statement Metrics:
  • Aquestive Therapeutics Inc EBITDA for the quarter ending December 12, 2018 was $-12m a 154.38% decrease of -18m year over year
  • Aquestive Therapeutics Inc Net Income for the quarter ending December 12, 2018 was $-14m a 129.40% decrease of -18m year over year
  • Aquestive Therapeutics Inc Total Revenue for the quarter ending December 12, 2018 was $17m a -39.15% decrease of -7m year over year
View Chart On Koyfin

Quarterly AQST Cost of Goods Sold Data

12/2018$5m
09/2018$6m
06/2018$5m
03/2018$6m
12/2017$6m
09/2017$5m
06/2017$5m
03/2017$4m
06/2007$1m
03/2007$0m

Annual AQST Cost of Goods Sold Data

2018$21m
2017$20m
2016$16m
2006$2m
2005$1m
2004$1m